U.S. District Court rules against the Sugar Association’s request to inspect Tate & Lyle’s SPLENDA® Sucralose facility in Alabama
On 14 August, a motion by the Sugar Association to compel the inspection of Tate Lyle’s U.S. SPLENDA® Sucralose facility was quashed by the U.S. District Court in Mobile, Alabama. The request for a court order to tour, inspect and videotape the process for making SPLENDA® Sucralose, arose as part of a federal lawsuit between the Sugar Association and McNeil Nutritionals LLC, to which Tate Lyle was not party.
Austin Maguire, President of Tate Lyle Sucralose said, “We are pleased that the District Court has ruled against the Sugar Association. Like any business, we seek to protect our intellectual property and manufacturing know-how and so access to our manufacturing facilities by competitors is understandably restricted.”
Since its launch, SPLENDA® Sucralose has become the no-calorie sweetener of choice for the U.S. consumer as both a food ingredient and as the sweetening component in the Nation’s favorite no calorie tabletop sweetener. Its great taste has set a new standard for the sweetness consumers expect in reduced-sugar or reduced-calorie products.
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
